Patents by Inventor Peiyong Huang

Peiyong Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7358259
    Abstract: The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: April 15, 2008
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Sambaiah Thota, Ankush Argade, Rajinder Singh, Henry H. Lu, Peiyong Huang
  • Publication number: 20070149520
    Abstract: The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
    Type: Application
    Filed: December 7, 2006
    Publication date: June 28, 2007
    Applicant: RIGEL PHARMACEUTICALS, INC.
    Inventors: Sambaiah Thota, Ankush Argade, Rajinder Singh, Henry Lu, Peiyong Huang
  • Publication number: 20050090521
    Abstract: The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
    Type: Application
    Filed: September 27, 2004
    Publication date: April 28, 2005
    Inventors: Sambaiah Thota, Ankush Argade, Rajinder Singh, Henry Lu, Peiyong Huang
  • Publication number: 20030219723
    Abstract: The field of the invention is methods for screening for effector peptides, polypeptides and fragments thereof and RNA molecules selected inside living cells that have anti-HCV activity.
    Type: Application
    Filed: May 20, 2002
    Publication date: November 27, 2003
    Inventors: Henry H. Lu, Peiyong Huang, Todd Kinsella, Anthony Martinez